IDEX BIOMETRICS ASA

0191 OSLO

Finances

Return on Equity

−143 %

Current Ratio

4,74

Debt-to-Equity Ratio

0,05

Key figures (USD)	2022	2021	2020	2019
Revenue	4 091 000	2 840 000	1 095 000	3 724 000
Net Income	−32 662 000	−32 552 000	−26 754 000	−285 334 000
Total Assets	29 016 000	42 026 000	17 006 000	206 074 000
Total Equity	22 841 000	37 725 000	12 514 000	156 405 000

Income (USD)	2022	2021	2020	2019
Revenue	4 091 000	2 840 000	1 095 000	3 724 000
Expenditure	35 461 000	34 190 000	27 497 000	285 742 000
Operating Profit	−31 370 000	−31 350 000	−26 402 000	−282 018 000
Financial Income	97 000	11 000	26 000	0
Financial Costs	1 425 000	1 123 000	477 000	1 904 000
Financial Balance	−1 328 000	−1 112 000	−451 000	−1 904 000
Earnings Before Tax	−32 698 000	−32 462 000	−26 853 000	−283 922 000
Tax	−36 000	90 000	−99 000	1 412 000
Net Income	−32 662 000	−32 552 000	−26 754 000	−285 334 000

Balance (USD)	2022	2021	2020	2019
Total Fixed Assets	5 181 000	4 678 000	6 168 000	62 214 000
Total Current Assets	23 835 000	37 348 000	10 838 000	143 860 000
Total Assets	29 016 000	42 026 000	17 006 000	206 074 000
Total Retained Equity	−27 533 000	−13 551 000	−27 009 000	−1 534 220 000
Total Equity	22 841 000	37 725 000	12 514 000	156 405 000
Total Long-Term Debt	1 142 000	11 000	327 000	5 626 000
Total Current Debt	5 033 000	4 290 000	4 165 000	44 045 000
Total Equity and Debt	29 016 000	42 026 000	17 006 000	206 076 000

Cash flow (USD)	2022	2021	2020	2019
Sales Income	4 091 000	2 840 000	1 013 000	1 396 000
Other Income	0	0	82 000	2 328 000
Revenue	4 091 000	2 840 000	1 095 000	3 724 000
Cost of Goods Sold	3 244 000	1 254 000	275 000	547 000
Salary Costs	19 213 000	21 107 000	17 672 000	191 396 000
Depreciation	1 352 000	1 802 000	1 719 000	14 372 000
Impairment	0	0	0	0
Expenditure	35 461 000	34 190 000	27 497 000	285 742 000
Operating Profit	−31 370 000	−31 350 000	−26 402 000	−282 018 000
Financial Income	97 000	11 000	26 000	0
Financial Costs	1 425 000	1 123 000	477 000	1 904 000
Financial Balance	−1 328 000	−1 112 000	−451 000	−1 904 000
Dividends	0	0	0	0
Net Income	−32 662 000	−32 552 000	−26 754 000	−285 334 000

Balance details (USD)	2022	2021	2020	2019
Goodwill	968 000	968 000	968 000	8 260 000
Total Intangible Assets	2 456 000	2 933 000	3 410 000	31 130 000
Real Eastate	1 545 000	357 000	1 016 000	0
Machinery and Plant Facilities	0	0	0	29 748 000
Fixtures	1 107 000	1 301 000	1 667 000	0
Total Tangible Assets	2 652 000	1 658 000	2 683 000	29 748 000
Total Fiancial Fixed Assets	73 000	87 000	75 000	1 336 000
Total Fixed Assets	5 181 000	4 678 000	6 168 000	62 214 000
Stock	4 447 000	1 234 000	859 000	6 026 000
Total Investments	0	0	0	0
Cash, Bank	16 124 000	33 759 000	7 298 000	124 031 000
Total Current Assets	23 835 000	37 348 000	10 838 000	143 860 000
Total Assets	29 016 000	42 026 000	17 006 000	206 074 000
Total Equity	22 841 000	37 725 000	12 514 000	156 405 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	1 142 000	11 000	327 000	5 626 000
Creditors	1 540 000	685 000	0	4 062 000
Unpaid Taxes	394 000	393 000	0	3 153 000
Dividends	0	0	0	0
Other Current Debt	3 099 000	3 212 000	4 165 000	35 696 000
Total Current Debt	5 033 000	4 290 000	4 165 000	44 045 000
Total Equity and Debt	29 016 000	42 026 000	17 006 000	206 076 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−143 %	−86,29 %	−213,79 %	−182,43 %
Debt-to-Equity Ratio	0,05	0	0,03	0,04
Operating Profit Margin	−766,81 %	−1 103,87 %	−2 411,14 %	−7 572,99 %
Current Ratio	4,74	8,71	2,6	3,27
Quick Ratio	40,67	12,22	3,28	3,78
Equity Ratio	0,79	0,9	0,74	0,76
Gross Profit Margin	20,7 %	55,85 %	74,89 %	85,31 %